+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Central Nervous System Drugs Market Research Reports

Friedreich Ataxia - Global Clinical Trials Review, 2022 - Product Thumbnail Image

Friedreich Ataxia - Global Clinical Trials Review, 2022

  • Clinical Trials
  • February 2022
  • 91 Pages
  • Global
From
Trigeminal Neuralgia (Tic Douloureux) - Global Clinical Trials Review, 2022 - Product Thumbnail Image

Trigeminal Neuralgia (Tic Douloureux) - Global Clinical Trials Review, 2022

  • Clinical Trials
  • February 2022
  • 96 Pages
  • Global
From
Huntington Disease - Global Clinical Trials Review, 2022 - Product Thumbnail Image

Huntington Disease - Global Clinical Trials Review, 2022

  • Clinical Trials
  • January 2022
  • 157 Pages
  • Global
From
Autism - Global Clinical Trials Review, 2022 - Product Thumbnail Image

Autism - Global Clinical Trials Review, 2022

  • Clinical Trials
  • January 2022
  • 419 Pages
  • Global
From
Postherpetic Neuralgia - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Postherpetic Neuralgia - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • December 2021
  • 283 Pages
  • Global
From
Migraine - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Migraine - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • November 2021
  • 985 Pages
  • Global
From
Cerebral Palsy - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Cerebral Palsy - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • November 2021
  • 198 Pages
  • Global
From
Migraine - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Migraine - Global Drug Forecast and Market Analysis to 2030

  • Report
  • November 2021
  • 131 Pages
  • Global
From
Traumatic Brain Injury - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Traumatic Brain Injury - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • October 2021
  • 395 Pages
  • Global
From
From
From
From
From
Alzheimer's Disease: Epidemiology Forecast to 2028 - Product Thumbnail Image

Alzheimer's Disease: Epidemiology Forecast to 2028

  • Report
  • May 2020
  • 47 Pages
  • Global
From
From
Loading Indicator

The Central Nervous System Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs that target the central nervous system. These drugs are used to treat a variety of conditions, including neurological disorders, mental health issues, and pain management. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. The Central Nervous System Drugs market is highly competitive, with companies competing to develop the most effective and safe treatments. Companies in the market are constantly researching and developing new drugs, as well as improving existing treatments. Many of these companies are also involved in clinical trials to test the safety and efficacy of their products. Some of the major companies in the Central Nervous System Drugs market include Pfizer, GlaxoSmithKline, Merck, Novartis, and Johnson & Johnson. These companies are involved in the development and production of a wide range of CNS drugs, including antidepressants, antipsychotics, and anticonvulsants. Show Less Read more